about
Artemisinin-based combination therapies: a vital tool in efforts to eliminate malariaSevere falciparum malaria. World Health Organization, Communicable Diseases ClusterAmodiaquine-associated adverse effects after inadvertent overdose and after a standard therapeutic dose.Fixed dose artesunate amodiaquine - a phase IIb, randomized comparative trial with non-fixed artesunate amodiaquine.Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria.Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy.CYP2C8 and antimalaria drug efficacy.Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria.Amodiaquine pharmacogenetics.Drug treatment and prevention of malaria.Replacement of the 4'-hydroxy group of amodiaquine and amopyroquine by aromatic and aliphatic substituents: synthesis and antimalarial activity.Assessment of formulated amodiaquine microparticles in Leishmania donovani infected rats.Antimalarial 4-aminoquinolines: mode of action and pharmacokinetics.Novel aryl-bis-quinolines with antimalarial activity in-vivo.Amodiaquine metabolism is impaired by common polymorphisms in CYP2C8: implications for malaria treatment in Africa.Tissue distribution and excretion of amodiaquine in the rat.Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria.Development of a novel mouse model of amodiaquine-induced liver injury with a delayed onset.Exploring an animal model of amodiaquine-induced liver injury in rats and mice.
P2860
Q24614989-E2180418-F034-4A11-A905-79465AD13935Q29614923-5CBA0274-7863-44E0-AA36-3015561A193FQ33605669-CDF80E50-2E95-4EAA-8CAB-74DC648D0B12Q34996451-79803CE0-FAC0-4F91-8C2A-AEF0DF09ECCEQ35244822-8A3E0D1B-9C09-4818-8855-ECE024B79ED5Q35316198-C0BCA13F-256F-4878-9AAB-333452030C89Q36364248-05A42D71-DDA1-40C8-B41C-FFB8450A153FQ36730638-9FCED76B-E2BA-4F87-AF28-BB28B2BB34C6Q36993430-7FB00C89-9918-4298-8470-BA3B45D0EA64Q37293982-2FA62B00-A45A-4FAA-B9A8-B7F613E33F55Q39590158-8A33B493-761D-44C2-B5AF-6D468D07AB02Q39884390-4C431930-F6C1-4C50-9935-C0C8AE16089AQ40379994-C2444395-93F4-4E5B-A830-67AF2D3C8B12Q40751922-17FF8BDE-B061-4E07-9BCE-E7F0F011479DQ41926200-7197802F-6739-408B-BDF1-1A21D9B84D71Q43932822-5EE34E91-546A-4133-9CF8-B29B2C565715Q44349730-2FA9F5DE-4ED0-472B-9676-8014D333C1ABQ47837569-8D70C87A-91AB-402B-9907-DB9EC899406EQ51126002-649FFD1E-B8E8-45B0-812F-CDB94F8D0CF5Q51641836-E1DB85E2-2DE6-4588-A24B-326DD6DACD5D
P2860
description
1987 nî lūn-bûn
@nan
1987 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Pharmacokinetics of intravenous amodiaquine.
@ast
Pharmacokinetics of intravenous amodiaquine.
@en
Pharmacokinetics of intravenous amodiaquine.
@nl
type
label
Pharmacokinetics of intravenous amodiaquine.
@ast
Pharmacokinetics of intravenous amodiaquine.
@en
Pharmacokinetics of intravenous amodiaquine.
@nl
prefLabel
Pharmacokinetics of intravenous amodiaquine.
@ast
Pharmacokinetics of intravenous amodiaquine.
@en
Pharmacokinetics of intravenous amodiaquine.
@nl
P2093
P2860
P50
P1476
Pharmacokinetics of intravenous amodiaquine.
@en
P2093
P2860
P304
P356
10.1111/J.1365-2125.1987.TB03020.X
P407
P577
1987-02-01T00:00:00Z